Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 419 | 676 | 277 | 1,410 | 238 |
| Gross Profit | 419 | 676 | 277 | 1,410 | 238 |
| Operating Expenses | 40,755 | 26,787 | 30,749 | 18,386 | 31,454 |
| Operating Income | -40,336 | -26,111 | -30,472 | -16,976 | -31,216 |
| Interest Expense | 449 | 455 | 457 | 477 | 492 |
| Other Income | 287 | 538 | 94 | 39 | 50 |
| Pre-tax Income | -40,498 | -26,028 | -30,835 | -17,414 | -31,658 |
| Net Income Continuous | -40,498 | -26,028 | -30,835 | -17,414 | -31,658 |
| Net Income | $-40,498 | $-26,028 | $-30,835 | $-17,414 | $-31,658 |
| EPS Basic Total Ops | -0.55 | -0.35 | -0.42 | -0.23 | -0.42 |
| EPS Basic Continuous Ops | -0.55 | -0.35 | -0.42 | -0.24 | -0.43 |
| EPS Diluted Total Ops | -0.55 | -0.35 | -0.42 | -0.23 | -0.42 |
| EPS Diluted Continuous Ops | -0.55 | -0.35 | -0.42 | -0.24 | -0.43 |
| EBITDA(a) | $-39,798 | $-25,532 | $-29,828 | $-16,307 | $-30,640 |